Cite
HARVARD Citation
Ksienski, D. et al. (2021). Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort. Clinical oncology. 33 (12), pp. e561-e569. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ksienski, D. et al. (2021). Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort. Clinical oncology. 33 (12), pp. e561-e569. [Online].